Calvert Investment Management’s ResMed RMD Stock Holding History

Calvert Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-88,653	Closed	-$5.5M	–	479
2016 Q4	$5.5M	Sell	88,653 -31,988	-27%	-$1.96M	0.21%	144
2016 Q3	$7.82M	Sell	120,641 -13,622	-10%	-$907K	0.29%	106
2016 Q2	$8.49M	Buy	134,263 +125,923	+1,510%	+$7.42M	0.34%	91
2016 Q1	$482K	Buy	8,340 +1,520	+22%	+$86K	0.02%	496
2015 Q4	$366K	Buy	6,820 +1,398	+26%	+$78.8K	0.02%	518
2015 Q3	$276K	Buy	5,422 +218	+4%	+$11.7K	0.01%	500
2015 Q2	$293K	Sell	5,204 -827	-14%	-$52.2K	0.01%	510
2015 Q1	$433K	Buy	6,031 +831	+16%	+$54K	0.03%	389
2014 Q4	$292K	Buy	5,200 +59	+1%	+$3.08K	0.02%	469
2014 Q3	$253K	Buy	+5,141	New	+$262K	0.02%	491

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Calvert Investment Management's RMD Position: Q1 2017 in Review

Calvert Investment Management sold out of ResMed (RMD) in Q1 2017, closing a stake of 88,653 shares — an estimated $5.5M sold.

Calvert Investment Management first reported a position in RMD in Q3 2014 and held it in 10 quarters. The position peaked at $8.49M in Q2 2016. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2017.

Calvert Investment Management reported no remaining ResMed position as of Q1 2017 after selling out during the quarter.
Calvert Investment Management sold 88,653 ResMed shares in Q1 2017, an estimated $5.5M.
Calvert Investment Management first reported a position in ResMed in Q3 2014 and held it in 10 quarters.
Calvert Investment Management's ResMed position peaked at $8.49M in Q2 2016.
374 funds tracked by Wall St. Rank held ResMed as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.